Table 1 Parameters describing organ function and systemic inflammation in sham-operated animals with and without MSC administration. Parameter Timepoint CONTROL MSC-CONTROL Urea (mmol/L) Baseline 5 (4.2–5.5) 5.7 (5–6.6) +12 H 5.5 (3.6–5.9) 6.1 (5.1–7.3)* +18 H 5 (3.3–5.6) 5.5 (4.5–6.6) +24 H 4.4 (3.2–4.6) 4.7 (3.8–5.8)* Creatinine (μmol/L) Baseline 95 (80–103) 99 (87–110) +12 H 93 (77–108) 100 (88–107) +18 H 88 (77–102) 95 (86–102) +24 H 85 (68–93) 89 (83–103) AST (μkat/L) Baseline 0.7 (0.6–1.5) 0.8 (0.6–1.9) +12 H 0.8 (0.7–1.4) 0.9 (0.8–1.1) +18 H 0.8 (0.7–1.6) 1.0 (0.9–1.5) +24 H 0.8 (0.7–1.4) 1.0 (0.9–1.4) ALT (μkat/L) Baseline 0.5 (0.5–0.7) 0.6 (0.5–0.7) +12 H 0.5 (0.5–0.6) 0.5 (0.48–0.51)* +18 H 0.5 (0.4–0.6) 0.5 (0.47–0.50)* +24 H 0.5 (0.4–0.5)* 0.52 (0.5–0.5)* Trombocytes (1 × 109/L) Baseline 285 (226–315) 260 (231–357) +12 H 227 (204–302) 200 (191–236)* +18 H 236 (213–271) 201 (164–220)* +24 H 241 (216–252) 194 (190–226)* PaO2/FiO2 (mmHg) Baseline 459 (410–510) 450 (441–466) +12 H 408 (399–460) 452 (410–455) +18 H 344 (262–404)* 355 (327–414)* +24 H 272 (232–353)* 313 (187–412)* hsTnT (ng/L) Baseline 7.2 (6.2–18.1) 9.7 (7.4–36.3) +12 H 7.7 (6.7–21.6) 9.2 (7.6–24.8) +18 H 6.1 (5.6–17.4)* 9 (7.1–19.9) +24 H 5.9 (4.5–17.8)* 10.5 (6.6–18.7) IL-6 (ng/L) Baseline 47 (36–75) 59 (47–114) +12 H 48 (30–63) 38 (16–64) +18 H 64 (48–212) 61 (33–66) +24 H 352 (139–1,451)* 175 (35–768) TNF-α (ng/L) Baseline 91.3 (77.7–123.2) 100.3 (62.1–145.1) +12 H 58.9 (54.2–89.5) 52.7 (38.8–75.8)* +18 H 60.0 (53.4–68.5) 59.3 (50.7–88.9)* +24 H 76.5 (61.5–119.3) 94.2 (57.4–112.2) 8-Isoprostane (μg/L) Baseline 32.0 (4.9–55.8) 43.3 (23.0–93.2) +12 H 8.4 (6.7–28.5) 23.5 (11.6–31.3) +18 H 5.7 (4.9–14.1) 15.1 (4.0–37.1) +24 H 6.7 (4–72.3) 55.6 (14.1–89.4) AST, aspartate aminotransferase; ALT, alanine aminotransferase; PaO2/FiO2, oxygenation index; hsTnT, high-sensitivity troponin T; IL-6, interleukin 6; TNF-α, tumor necrosis factor α. * p < 0.05 between baseline and time-point. No statistical significance was found between groups.